{
  "resourceType" : "ResearchStudy",
  "id" : "Example-Trial",
  "version": "0.0.1",
  "status": "draft",
  "name": "ramona2",
  "title": "RAMONA II - Die nächste Studie",
  "identifier" : [
    {
      "system" : "http://clinicaltrials.gov",
      "value" : "NCT04360330"
    },
    {
      "system" : "http://www.drks.de",
      "value" : "DRKS00010757"
    },
    {
      "system" : "http://molit.eu/fhir/sid/trials",
      "value" : "123456789"
    }
  ], 
  "date": "2023-05-26T00:17:51+00:00",
  "region": [{
      "coding": [{
	"system": "urn:iso:std:iso:3166",
	"code": "DE",
        "display": "Deutschland"
       }]
   }],
   "focus" : [{
    "coding" : [{
      "system" : "http://www.whocc.no/atc",
      "code" : "A01AB07",
      "display" : "oxyquinoline"
    }]
  }], 
  "condition" : [{
    "coding" : [{
      "system" : "http://fhir.de/CodeSystem/dimdi/icd-10-gm",
      "code" : "C25",
      "display" : "Bösartige Neubildung des Pankreas"
    }]
  }], 
  "description" : "Diese Studie untersucht die Zusammenhänge der bösartigen Pankreas Neubildungen in Verbindung mit Adenokarzinomen.",
  "site" : [{
    "reference" : "Location/SLK"
  }],
  "recruitment" : {
    "targetNumber" : "Group/TrialInclusionGroupExample",
    "actualNumber" : "Group/TrialInclusionGroupExample"
  }
}
